“…This overlap can pose a diagnostic challenge, especially in patients who are at risk for both PTLD and disseminated infections. 36,38 Early detection and management of PTLD are critical in improving outcomes for affected individuals. Treatment options such as reducing immunosuppression, antiviral therapy, rituximab (an anti-CD20 monoclonal antibody), chemotherapy, or radiation therapy may be considered depending on the severity and type of PTLD.…”